AMPHIKTION
ActiveSummary
AMPHIKTION is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. For AMPHIKTION, one filing cycle of the annual accounts is missing. The 2024 annual accounts show negative equity (-€196,258) and a net result of €33,500, of which €77,163 non-recurring income. Its solvency ranks better than 5% of 9,699 sector peers (NACE 64, financial year 2024). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.
Directors
Directors
1 director, no change since 2023
Board 1
PharmaLegal
CurrentDirector · since 07-07-2023 · Private limited company (pre-2019) · permanent representative: DE FEU Georges Charlotte Jan Madelaine
Permanent representatives 1
DE FEU Georges Charlotte Jan Madelaine
CurrentPermanent representative · since 07-07-2023 · for PharmaLegal
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Mandate history
1 person since 2023, 1 in office
- Board
| Name | Functions and periods |
|---|---|
| PharmaLegal |
|
Owners and capital
Capital and shareholders
Shareholders according to the deeds
Stated in the act
act of 09-12-2024 ↗
- LEBA 400 shares
At incorporation
act of 07-07-2023 ↗
- DE FEU Georges Charlotte Jan Madelaine 10 shares (2.3%)
- PharmaLegal (BE 0541.432.719) 30 shares (6.8%)
- LEBA (BE 0439.950.032) 400 shares (90.9%)
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
Capital over the years
- 07-07-2023 Incorporation · €440,000 · 440 shares